IGF-I activates the insulin receptor substrate 1 (IRS-1) protein, which is known to be up-regulated in human HCC, and induces malignant transformation through activation of the mitogen-activated protein kinase (MAPK) cascade [25]. Here, IGF1 is linked to hepatocellular carcinoma.